Clinical and pathological factors | Disease-free survival | P value | Melanoma-specific survival | P value |
---|---|---|---|---|
Method of diagnosis | Â | 0.6 | Â | 0.01 |
Sentinel lymph node biopsy | 1 | Â | 1 | Â |
Clinical | 1.1 (0.7 to 1.7) | Â | 1.7 (1.0 to 3.0) | Â |
Primary sitea | Â | 0.05 | Â | 0.07 |
Trunk | 1 | Â | 1 | Â |
Lower extremity | 0.5 (0.3 to 0.9) | Â | 0.6 (0.3 to 1.1) | Â |
Unknown | 1.1 (0.3 to 3.6) | Â | 21.7 (0.5 to 5.6) | Â |
T stage | Â | 0.05 | Â | 0.09 |
T1 to T2 | 1 | Â | 1 | Â |
T3 | 2.2 (1.2 to 4.1) | Â | 2.5 (1.1 to 5.6) | Â |
T4 | 1.6 (0.8 to 3.0) | Â | 1.6 (0.6 to 3.8) | Â |
Ulcerationb | Â | 0.3 | Â | 0.06 |
No | 1 | Â | 1 | Â |
Yes | 1.3 (0.7 to 2.3) | Â | 1.9 (1.0 to 3.7) | Â |
Number of positive lymph nodes | Â | 0.006 | Â | 0.003 |
1 (N1) | 1 | Â | 1 | Â |
2 or 3 (N2) | 1.2 (0.6 to 2.2) | Â | 1.6 (0.7 to 3.5) | Â |
≥4 (N3) | 3.6 (1.6 to 7.8) |  | 4.7 (1.9 to 11.5) |  |
Extent of nodal involvement | Â | 0.001 | Â | 0.002 |
Superficial | 1 | Â | 1 | Â |
Superficial + deep | 2.6 (1.4 to 4.6) | Â | 2.8 (1.5 to 5.5) | Â |